Novus Therapeutics Revenue

Biotechnology Research • Irvine, California, United States • 1-10 Employees

Novus Therapeutics revenue & valuation

Annual revenue	$120,000
Revenue per employee	$120,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$384,000
Total funding	No funding

Key Contact at Novus Therapeutics

Julie Roth

Director

Company overview

Headquarters	19900 MacArthur Blvd, Suite 550, Irvine, Ca 92612, US
Websites	novustherapeutics.com eledon.com
NAICS	541714
Keywords	Biotechnology, Clinical Development, ALS, Transplant, Autoimmune Diseases, Type 1 Diabetes, Lupus Nephritis, Renal Transplant, Islet Cell Transplant
Founded	2017
Employees	1-10

About Novus Therapeutics

Novus Therapeutics, Inc. (NASDAQ: NVUS) is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cell-based transplant, and for people with autoimmune and neurodegenerative disease.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Novus Therapeutics has never raised funding before.

Novus Therapeutics Tech Stack

Discover the technologies and tools that power Novus Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

PWA

Miscellaneous

Zendesk

Documentation

Microsoft 365

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

Adobe Fonts

Font scripts

Google Tag Manager

Tag managers

Frequently asked questions

Novus Therapeutics is located in Irvine, California, US.

Novus Therapeutics generates an estimated annual revenue of $120,000. This revenue figure reflects the company's market position and business performance in its industry.

Novus Therapeutics has an estimated valuation of $384,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Novus Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Novus Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Novus Therapeutics

Julie Roth

Director

4.8

40,000 users